Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 2, Pages 893-904
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2011-11-19
DOI
10.1074/jbc.m111.306472
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
- (2012) Miguel Medina et al. CURRENT PHARMACEUTICAL DESIGN
- 2011 Alzheimer’s disease facts and figures
- (2011) Alzheimers & Dementia
- Aβ1–42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
- (2011) Jihoon Jo et al. NATURE NEUROSCIENCE
- The resurgence of covalent drugs
- (2011) Juswinder Singh et al. NATURE REVIEWS DRUG DISCOVERY
- Phase IIa clinical trial on Alzheimer's disease with NP12, a GSK3 inhibitor
- (2010) Teodoro del Ser Alzheimers & Dementia
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- Characterization of Irreversible Kinase Inhibitors by Directly Detecting Covalent Bond Formation: A Tool for Dissecting Kinase Drug Resistance
- (2010) Sabine Klüter et al. CHEMBIOCHEM
- Glycogen synthase kinase-3β, or a link between amyloid and tau pathology?
- (2010) D. Muyllaert et al. GENES BRAIN AND BEHAVIOR
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- GSK3: A possible link between beta amyloid peptide and tau protein
- (2009) Félix Hernández et al. EXPERIMENTAL NEUROLOGY
- Phosphorylation of Neuronal Survival Factor MEF2D by Glycogen Synthase Kinase 3β in Neuronal Apoptosis
- (2009) Xuemin Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel GSK-3β inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo
- (2009) L. Serenó et al. NEUROBIOLOGY OF DISEASE
- Synaptic transmission block by presynaptic injection of oligomeric amyloid beta
- (2009) H. Moreno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epistasis between tau phosphorylation regulating genes (CDK5R1 and GSK-3β) and Alzheimer’s disease risk
- (2008) I. Mateo et al. ACTA NEUROLOGICA SCANDINAVICA
- Glycogen synthase kinase-3β and tau genes interact in Alzheimer's disease
- (2008) John B. J. Kwok et al. ANNALS OF NEUROLOGY
- Association of GSK3B With Alzheimer Disease and Frontotemporal Dementia
- (2008) Barbara A. J. Schaffer et al. ARCHIVES OF NEUROLOGY
- Mitochondrial Hexokinase II Promotes Neuronal Survival and Acts Downstream of Glycogen Synthase Kinase-3
- (2008) Alfredo Gimenez-Cassina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Wnt Pool of Glycogen Synthase Kinase 3 Is Critical for Trophic-Deprivation-Induced Neuronal Death
- (2008) V. Hongisto et al. MOLECULAR AND CELLULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search